Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Y Dodd

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Vox Sanguinis|July 1, 1980
Hepatitis-associated markers in the American Red Cross volunteer blood donor population. I. Trends in HBsAg detection, 1975--1978M J Bastiaans, R Y Dodd, N Nath, et al.
Transfusion|November 14, 1997
Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study GroupM P Busch, R Y Dodd, E M Lackritz, et al.
Archives of Internal Medicine|March 1, 1991
Human immunodeficiency virus infection and indeterminate western blot patterns. Prospective studies in a low prevalence populationN L Dock, S H Kleinman, M A Rayfield, et al.
Vox Sanguinis|August 1, 1980
Hepatitis-associated markers in the American Red Cross volunteer blood donor population. ii. Distribution of level of HBsAg reactivity by radioimmunoassay and occurrence of nonspecific reactivityN Nath, C T Fang, H Berberian, et al.
Transfusion|August 1, 1997
Serologic test for syphilis as a surrogate marker for human immunodeficiency virus infection among United States blood donorsG A Herrera, E M Lackritz, R S Janssen, et al.
Transfusion|July 1, 1991
Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: comparison of psoralen-ultraviolet A and merocyanine 540-visible light methodsR Y Dodd, G Moroff, S Wagner, et al.
Transfusion|October 1, 1994
The effectiveness of the confidential unit exclusion optionL R Petersen, E Lackritz, W F Lewis, et al.
The Journal of Infectious Diseases|October 23, 1997
Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donorsD A Leiby, E J Read, B A Lenes, et al.
The West Indian Medical Journal|June 1, 1995
Prevalence of antibodies to hepatitis C virus and other markers in JamaicaS D King, R Y Dodd, G Haynes, et al.
Emerging Infectious Diseases|August 26, 1998
Blood safetyM E Chamberland, J Epstein, R Y Dodd, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Vox Sanguinis|July 1, 1980
Hepatitis-associated markers in the American Red Cross volunteer blood donor population. I. Trends in HBsAg detection, 1975--1978M J Bastiaans, R Y Dodd, N Nath, et al.
Transfusion|November 14, 1997
Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study GroupM P Busch, R Y Dodd, E M Lackritz, et al.
Archives of Internal Medicine|March 1, 1991
Human immunodeficiency virus infection and indeterminate western blot patterns. Prospective studies in a low prevalence populationN L Dock, S H Kleinman, M A Rayfield, et al.
Vox Sanguinis|August 1, 1980
Hepatitis-associated markers in the American Red Cross volunteer blood donor population. ii. Distribution of level of HBsAg reactivity by radioimmunoassay and occurrence of nonspecific reactivityN Nath, C T Fang, H Berberian, et al.
Transfusion|August 1, 1997
Serologic test for syphilis as a surrogate marker for human immunodeficiency virus infection among United States blood donorsG A Herrera, E M Lackritz, R S Janssen, et al.
Transfusion|July 1, 1991
Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: comparison of psoralen-ultraviolet A and merocyanine 540-visible light methodsR Y Dodd, G Moroff, S Wagner, et al.
Transfusion|October 1, 1994
The effectiveness of the confidential unit exclusion optionL R Petersen, E Lackritz, W F Lewis, et al.
The Journal of Infectious Diseases|October 23, 1997
Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donorsD A Leiby, E J Read, B A Lenes, et al.
The West Indian Medical Journal|June 1, 1995
Prevalence of antibodies to hepatitis C virus and other markers in JamaicaS D King, R Y Dodd, G Haynes, et al.
Emerging Infectious Diseases|August 26, 1998
Blood safetyM E Chamberland, J Epstein, R Y Dodd, et al.
Pageof 12